A 3′UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1
A 3′UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1
About this item
Full title
Author / Creator
Publisher
London: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central
Subjects
More information
Scope and Contents
Contents
Doc number: 87 Abstract Background: The Polo-like Kinase 1 (PLK1) protein regulates cell cycle progression and is overexpressed in many malignant tissues. Overexpression is associated with poor prognosis in several cancer entities, whereby expression of PLK1 shows high inter-individual variability. Although PLK1 is extensively studied, not much is...
Alternative Titles
Full title
A 3′UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4020576
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4020576
Other Identifiers
ISSN
1476-4598
E-ISSN
1476-4598
DOI
10.1186/1476-4598-13-87
